Sage Journals: Discover world-class research

Free access

Research article

First published 2012-7

Tegafur–uracil is a safe alternative for the treatment of colorectal cancer in patients with partial dihydropyrimidine dehydrogenase deficiency: a proof of principle

Daniel I.G. Cubero, Felipe Melo Cruz, Patrícia Santi [...]

Therapeutic Advances in Medical Oncology

Retricted access

Case report

First published 2022-4

5-Fluorouracil Neurotoxicity in the Absence of Dihydropyrimidine Dehydrogenase Deficiency Case Report

Rebecca Jules, Arushi Thaper, Ryan Foster [...]

The Neurohospitalist

Free access

Review article

First published 2003-01

Pharmacogenetic and clinical aspects of dihydropyrimidine dehydrogenase deficiency

Annals of Clinical Biochemistry: International Journal of Laboratory Medicine

Retricted access

Case report

First published 2026

5-Fluorouracil-induced acute leukoencephalopathy in the absence of dihydropyrimidine dehydrogenase deficiency: A case report

Murrah Sabouni, Kristen Peterson, Audrey Kam

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2020-4

Fluoropyrimidine-induced toxicity and DPD deficiency.. A case report of early onset,lethal capecitabine-induced toxicity and mini review of the literature. Uridine triacetate: Efficacy and safety as an antidote. Is it accessible outside USA?

Dimitra Ioanna Lampropoulou, Konstantinos Laschos, Anna-Lea Amylidi [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2018-10

Cost Implications of Reactive Versus Prospective Testing for Dihydropyrimidine Dehydrogenase Deficiency in Patients With Colorectal Cancer: A Single-Institution Experience

Con Murphy, Stephen Byrne, Gul Ahmed [...]

Dose-Response

Free access

Letter

First published 2013-1

Standard-dose tegafur-uracil (UFT) is not a safe alternative in partial dihydropyrimidine dehydrogenase-deficient patients

Maarten J. Deenen, Annemieke Cats, Jos H. Beijnen [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2023

Renal impairment and abnormal liver function tests in pre-therapeutic phenotype-based DPD deficiency screening using uracilemia: a comprehensive population-based study in 1138 patients

Sidonie Callon, Mathias Brugel, Damien Botsen [...]

Therapeutic Advances in Medical Oncology

Free access

Letter

First published 2013-1

Tegafur-uracil (UFT) in lower doses is safe for the treatment of colorectal cancer in patients with partial dihydropyrimidine dehydrogenase deficiency: a proof of principle

Daniel I. G. Cubero, Auro del Giglio

Therapeutic Advances in Medical Oncology

Open access

Letter

First published 2019-10

Response to Letter: Cost Implications of Reactive Versus Prospective Testing for Dihydropyrimidine Dehydrogenase Deficiency in Patients With Colorectal Cancer: A Single-Institution Experience

Eoin O'Farrell, Brian Bird, Con Murphy

Dose-Response

Search results